Skip to main navigation Skip to search Skip to main content

Spironolactone versus placebo for patients experiencing heart failure with preserved ejection fraction: The IMPRESS-AF randomized controlled trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNIHR Journals Library
Publication statusAccepted/In press - 9 Mar 2020

Cite this